Journal articleContemporary Clinical Trials Communications · June 1, 2026
Persistent under-representation of certain racial, ethnic, or socio-demographic subgroups in clinical studies continues to put patients at risk for unfavorable health outcomes. In an environment where accrual increasingly relies on digital campaigns, we pr ...
Full textCite
Journal articleJMIR Diabetes · March 15, 2024
BACKGROUND: Digital health programs provide individualized support to patients with chronic diseases and their effectiveness is measured by the extent to which patients achieve target individual clinical outcomes and the program's ability to sustain patien ...
Full textOpen AccessLink to itemCite
Journal articlePsychiatry Res · March 2024
The Patient Health Questionnaire 9 (PHQ-9) is the current standard outpatient screening tool for measuring and tracking the nine symptoms of major depressive disorder (MDD). While the PHQ-9 was originally conceptualized as a unidimensional measure, it has ...
Full textOpen AccessLink to itemCite
Journal articleJ Diabetes Sci Technol · January 2024
This commentary article discusses the recent trends and changes in popularity of telehealth usage as well as the most recent efforts to redefine telehealth value and usability. Six strategies to improve the patient experience and increase telehealth accept ...
Full textOpen AccessLink to itemCite
Journal articleJ Public Health Manag Pract · November 2023
OBJECTIVE: Scalable strategies to reduce the time burden and increase contact tracing efficiency are crucial during early waves and peaks of infectious transmission. DESIGN: We enrolled a cohort of SARS-CoV-2-positive seed cases into a peer recruitment stu ...
Full textOpen AccessLink to itemCite
Journal articleDiabetes Care · July 1, 2023
The past decade of population research for diabetes has seen a dramatic proliferation of the use of real-world data (RWD) and real-world evidence (RWE) generation from non-research settings, including both health and non-health sources, to influence decisi ...
Full textLink to itemCite
Journal articleClin Pharmacol Ther · March 2023
Healthcare disparities are a persistent societal problem. One of the contributing factors to this status quo is the lack of diversity and representativeness of research efforts, which result in nongeneralizable evidence that, in turn, provides suboptimal m ...
Full textLink to itemCite
Journal articleJ Am Med Inform Assoc · August 16, 2022
Artificial intelligence/machine learning models are being rapidly developed and used in clinical practice. However, many models are deployed without a clear understanding of clinical or operational impact and frequently lack monitoring plans that can detec ...
Full textOpen AccessLink to itemCite
Journal articleAnn Surg · June 1, 2022
OBJECTIVE: To design and establish a prospective biospecimen repository that integrates multi-omics assays with clinical data to study mechanisms of controlled injury and healing. BACKGROUND: Elective surgery is an opportunity to understand both the system ...
Full textLink to itemCite
Journal articleMed · April 8, 2022
The promise of artificial intelligence (AI) and machine learning in healthcare can be realized only when they are smoothly integrated into existing clinical workflows. Doing so requires optimizing the user experience of AI and the data on which these syste ...
Full textLink to itemCite
Journal articleLancet Reg Health Am · September 2021
BACKGROUND: Non-Hispanic Black populations have suffered much greater per capita COVID-19 mortality than White populations. Previous work has shown that rates of Black and White mortality have converged over time. Understanding of COVID-19 disparities over ...
Full textOpen AccessLink to itemCite
Journal articleTrials · August 16, 2021
BACKGROUND: Interest in the application of machine learning (ML) to the design, conduct, and analysis of clinical trials has grown, but the evidence base for such applications has not been surveyed. This manuscript reviews the proceedings of a multi-stakeh ...
Full textOpen AccessLink to itemCite
Journal articleIEEE Internet Things J · August 15, 2021
As COVID-19 hounds the world, the common cause of finding a swift solution to manage the pandemic has brought together researchers, institutions, governments, and society at large. The Internet of Things (IoT), artificial intelligence (AI)-including machin ...
Full textLink to itemCite
Journal articleJ Surg Res · October 2020
BACKGROUND: Reduced surgical site infection (SSI) rates have been reported with use of closed incision negative pressure therapy (ciNPT) in high-risk patients. METHODS: A deep learning-based, risk-based prediction model was developed from a large national ...
Full textLink to itemCite
Journal articleNPJ Digit Med · 2020
Storing very large amounts of data and delivering them to researchers in an efficient, verifiable, and compliant manner, is one of the major challenges faced by health care providers and researchers in the life sciences. The electronic health record (EHR) ...
Full textOpen AccessLink to itemCite
Journal articleNPJ Digit Med · 2020
The Project Baseline Health Study (PBHS) was launched to map human health through a comprehensive understanding of both the health of an individual and how it relates to the broader population. The study will contribute to the creation of a biomedical info ...
Full textOpen AccessLink to itemCite
Journal articleSurgery · October 2018
The term big data has been popularized over the past decade and is often used to refer to data sets that are too large or complex to be analyzed by traditional means. Although the term has been utilized for some time in business and engineering, the concep ...
Full textLink to itemCite
Journal articleFront Microbiol · 2018
Background: Acute respiratory infections (ARIs) are the leading indication for antibacterial prescriptions despite a viral etiology in the majority of cases. The lack of available diagnostics to discriminate viral and bacterial etiologies contributes to th ...
Full textOpen AccessLink to itemCite
Journal articleEBioMedicine · March 2016
We previously identified 34 genes of interest (GOI) in 2006 to aid the oncologists to determine whether post-mastectomy radiotherapy (PMRT) is indicated for certain patients with breast cancer. At this time, an independent cohort of 135 patients having DNA ...
Full textLink to itemCite
Journal articleNeuro Oncol · November 2015
BACKGROUND: Despite an aggressive therapeutic approach, the prognosis for most patients with glioblastoma (GBM) remains poor. The aim of this study was to determine the significance of preoperative MRI variables, both quantitative and qualitative, with reg ...
Full textLink to itemCite
Journal articleClin Cancer Res · January 1, 2014
PURPOSE: KRAS wild-type status is an imperfect predictor of sensitivity to anti-EGF receptor (EGFR) monoclonal antibodies in colorectal cancer, motivating efforts to identify novel molecular aberrations driving RAS. This study aimed to build a quantitative ...
Full textLink to itemCite
Journal articleClin Cancer Res · August 15, 2013
The progressive introduction of high-throughput molecular techniques in the clinic allows for the extensive and systematic exploration of multiple biologic layers of tumors. Molecular profiles and classifiers generated from these assays represent the found ...
Full textLink to itemCite
Journal articleRadiology · May 2013
PURPOSE: To conduct a comprehensive analysis of radiologist-made assessments of glioblastoma (GBM) tumor size and composition by using a community-developed controlled terminology of magnetic resonance (MR) imaging visual features as they relate to genetic ...
Full textLink to itemCite
Journal articleSci Transl Med · April 17, 2013
Although molecular prognostics in breast cancer are among the most successful examples of translating genomic analysis to clinical applications, optimal approaches to breast cancer clinical risk prediction remain controversial. The Sage Bionetworks-DREAM B ...
Full textLink to itemCite
Journal articleCancer Research · April 15, 2013
AbstractBackground: KRAS mutation status alone is an imperfect predictor of response to anti-EGFR therapy in CRC, motivating efforts to identify additional molecular traits for RAS pathway activity. This stu ...
Full textCite
Journal articleClin Pharmacol Ther · April 2013
The explosive growth of molecular diagnostic tests introduces the possibility of increasing our understanding of disease mechanisms in the clinic and promises to improve target identification for new therapies. A new paradigm is emerging in drug discovery ...
Full textLink to itemCite
Journal articleBMC Med Genomics · July 22, 2011
BACKGROUND: Transgenic mouse tumor models have the advantage of facilitating controlled in vivo oncogenic perturbations in a common genetic background. This provides an idealized context for generating transcriptome-based diagnostic models while minimizing ...
Full textLink to itemCite
Journal article · December 1, 2010
Breast cancer is the second leading cause of death among females. As the most common cancer diagnosis in women, one out of every six American women will confront breast cancer during her lifetime. The disease is more common in industrialized Northern Ameri ...
Full textCite
Journal articleJ Clin Oncol · October 1, 2006
Featured Publication
PURPOSE: This study aims to explore gene expression profiles that are associated with locoregional (LR) recurrence in breast cancer after mastectomy. PATIENTS AND METHODS: A total of 94 breast cancer patients who underwent mastectomy between 1990 and 2001 ...
Full textLink to itemCite
Journal articleBiostatistics · October 2004
Featured Publication
Classification tree models are flexible analysis tools which have the ability to evaluate interactions among predictors as well as generate predictions for responses of interest. We describe Bayesian analysis of a specific class of tree models in which bin ...
Full textLink to itemCite
Journal articleProc Natl Acad Sci U S A · June 1, 2004
We describe a comprehensive modeling approach to combining genomic and clinical data for personalized prediction in disease outcome studies. This integrated clinicogenomic modeling framework is based on statistical classification tree models that evaluate ...
Full textLink to itemCite
Journal articleHum Mol Genet · October 15, 2003
Featured Publication
Genomic data, particularly genome-scale measures of gene expression derived from DNA microarray studies, has the potential for adding enormous information to the analysis of biological phenotypes. Perhaps the most successful application of this data has be ...
Full textLink to itemCite
Journal articleCancer Res · July 1, 2003
Featured Publication
The study of tumor suppressor gene function has been aided by the creation of discrete gene alterations in the mouse. One such example can be seen in the study of tumor suppressor gene function in general and the retinoblastoma (Rb) tumor suppressor in par ...
Link to itemCite
Journal articleNat Genet · June 2003
Featured Publication
High-density DNA microarrays measure expression of large numbers of genes in one assay. The ability to find underlying structure in complex gene expression data sets and rigorously test association of that structure with biological conditions is essential ...
Full textLink to itemCite
Journal articleLancet · May 10, 2003
Featured Publication
BACKGROUND: Correlation of risk factors with genomic data promises to provide specific treatment for individual patients, and needs interpretation of complex, multivariate patterns in gene expression data, as well as assessment of their ability to improve ...
Full textLink to itemCite
Journal articleRecent Prog Horm Res · 2003
Featured Publication
We have applied techniques of gene expression analysis to the analysis of human breast cancer by identifying metagene models with the capacity to discriminate breast tumors based on estrogen receptor (ER) status as well as the propensity for lymph node met ...
Full textLink to itemCite
Journal articleProc Natl Acad Sci U S A · September 25, 2001
Featured Publication
Prognostic and predictive factors are indispensable tools in the treatment of patients with neoplastic disease. For the most part, such factors rely on a few specific cell surface, histological, or gross pathologic features. Gene expression assays have the ...
Full textLink to itemCite
Journal articleMol Cell · July 2001
Featured Publication
Previous work has shown that the Myc transcription factor induces transcription of the E2F1, E2F2, and E2F3 genes. Using primary mouse embryo fibroblasts deleted for individual E2F genes, we now show that Myc-induced S phase and apoptosis requires distinct ...
Full textLink to itemCite
Journal articleMol Cell Biol · July 2001
Featured Publication
We have used high-density DNA microarrays to provide an analysis of gene regulation during the mammalian cell cycle and the role of E2F in this process. Cell cycle analysis was facilitated by a combined examination of gene control in serum-stimulated fibro ...
Full textLink to itemCite